Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2005
05/19/2005US20050106672 Neurotransmission associated proteins
05/19/2005US20050106670 Isolated human G-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human GPCR proteins, and uses thereof
05/19/2005US20050106669 Specific polynucleotides encoding them, as well as expression vectors and host cells; used for identifying compounds that inhibit an interaction between a Glutamate Transporter Associated Protein and a glutamate transporter protein, and for treating disorders associated with glutamate transport.
05/19/2005US20050106666 Glial mitogenic factors, their preparation and use
05/19/2005US20050106663 viral vector containing a polynucleotide sequence contains two different affinity tag sequences, one of the two affinity tag sequences encodes streptavidin-binding peptide and other encodes calmodulin binding peptide
05/19/2005US20050106662 Novel food grade lantibiotic from streptococcus macedonicus and uses thereof
05/19/2005US20050106660 Subjecting apoliprotein to mutagenesis at sequence positions 34 to 38 and other positions and muteins of aliproteins
05/19/2005US20050106659 Membrane protein for use as tool in detection of modulators for diagnosis, prevention and treatment of neurological and/or psychiatric diseases
05/19/2005US20050106658 Remodeling and glycoconjugation of peptides
05/19/2005US20050106654 Animal model lacking histone deacetylase (HDAC) for use as diagnostic tool in detection, diagnosis and prevention of cardiac hypertrophy
05/19/2005US20050106653 Method for the identification of IRS protein kinase inhibitors or agonist
05/19/2005US20050106638 Immunoglobulin for use in diagnosis, prevention and treatment of fibrosis and scarring; antiscarring agents
05/19/2005US20050106628 MEGSIN protein
05/19/2005US20050106622 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/19/2005US20050106614 Reagents and methods useful for detecting diseases of the prostate
05/19/2005US20050106611 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
05/19/2005US20050106601 Transgenic mouse whose somatic and germ cells express an Fkhsf transgene and mutants; immunomodulators
05/19/2005US20050106600 Immunoglobulin for use in diagnosis, prevention, and treatment of tumor progression in cells; immunodiagnostic and therapeutics
05/19/2005US20050106597 Nucleotide sequences coding bacterial polypeptides for use in generating antibodies to prevent and treat staphylococcal infection
05/19/2005US20050106569 Using concentration of paraneoplastic neuronal antigen (MA2) as diagnostic/prognostic risk indicator of nervous system disorders
05/19/2005US20050106565 Hybrid nucleic acids, ant antibodies thereof; insecticide
05/19/2005US20050106558 Generating viral expression vector comprising parvoviral structural genes for use as gene transfer and expression tool; treatment and prevention of infections, cell proliferative and autoimmune disorders
05/19/2005US20050106553 Rendering material suitable for storage via spraying into hot gas stream an aqueous mixture and carrier, drying mixture to particles , separating partiles from gas stream; storage of materials by incorporating them into water-soluble or water-swellable substance
05/19/2005US20050106266 docosahexaenoic acid and a calcium compound (carbonate, hydroxide,sulfate)
05/19/2005US20050106261 Rapid reduction of the alcohol level in blood; by use of multivalent transition metal ions and their complexes, and NAD+ which enhance the oxidation reaction
05/19/2005US20050106237 Orodispersible pharmaceutical composition comprising perindopril
05/19/2005US20050106218 Compositions and methods for treatment of body weight conditions
05/19/2005US20050106214 Excipients in drug delivery vehicles
05/19/2005US20050106211 Fabrication of drug loaded biodegradable polymer fibers
05/19/2005US20050106189 Pharmaceutical formulation comprising cyclosporin and use thereof
05/19/2005US20050106183 Method of treating pain
05/19/2005US20050106182 Rescue agents for treating botulinum toxin intoxications
05/19/2005US20050106179 Isolated complexes of endotoxin and MD-2
05/19/2005US20050106162 Immunisation against chlamydia trachomatis
05/19/2005US20050106161 Vaccine ; human leukemia, lymphoma virus
05/19/2005US20050106154 GASP1: a follistatin domain containing protein
05/19/2005US20050106151 Bacrtericides; viricides; administering antitrypsin; gramnedative, grampositive bacteria; anthrax
05/19/2005US20050106148 Method of treating blood disorders
05/19/2005US20050106146 Protein that controlles gastrointestinal system; therapy for nutritional homeostasis
05/19/2005US20050106145 Anti-human tenascin monoclonal antibody
05/19/2005US20050106144 Spondyloarthropathies
05/19/2005US20050106142 Rheumatic arthritis; hepatitis c virus; autoimmune diseases ; nterfering with forming or binding of such; autoantigen
05/19/2005US20050106135 Compositions, kits and treating methods for alteration cell-cell adhesion, transport, or permeation properties of tissues
05/19/2005US20050106134 Pregnancy-related enzyme activity
05/19/2005US20050106130 Transgenic human cells expressing antiproliferative agents; gene therapy; anticancer agents; tissue engineering; generating immunology response
05/19/2005US20050106128 Novel methods of treatment and deliver modes
05/19/2005US20050106124 Therapeutic applications of thrombomodulin gene via viral and non-viral vectors
05/19/2005US20050106108 Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells
05/19/2005US20050106102 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy
05/19/2005US20050106099 Fusion proteins
05/19/2005DE19905501B4 Verfahren zur Herstellung eines rekombinanten Adeno-assoziierten Virus, geeignete Mittel hierzu sowie Verwendung zur Herstellung eines Arzneimittels A method of producing a recombinant adeno-associated virus, as well as suitable means to this end use for the preparation of a medicament
05/19/2005DE10349511A1 Using fungal naphthopyran-8,9-diones as inhibitors of aspartyl protease, useful for treatment of infection by Candida or human immune deficiency virus
05/19/2005DE10148828B4 Modulation der Expression STAT-1-abhängiger Gene Modulating the expression of STAT-1-dependent genes
05/19/2005CA2830063A1 Stabilized alpha helical peptides and uses thereof
05/19/2005CA2586320A1 Bonding tissues and cross-linking proteins with naphthalimide compounds
05/19/2005CA2548538A1 Compositions and methods of use for a fibroblast growth factor
05/19/2005CA2545160A1 Variants of human glycoprotein hormone alpha chain: compositions and uses thereof
05/19/2005CA2544972A1 Use of interleukin-22 as a biomarker of resistance to hiv infections in humans and biological applications thereof
05/19/2005CA2544949A1 Antagonist anti-cd40 monoclonal antibodies and methods for their use
05/19/2005CA2544948A1 Methods of therapy for cancers expressing the cd40 antigen
05/19/2005CA2544924A1 Methods and compositions for treating mcp-1 related pathologies
05/19/2005CA2544853A1 Use of antagonist anti-cd40 antibodies for treatment of autoimmune and inflammatory diseases, and organ transplant rejection
05/19/2005CA2544807A1 Compositions and methods of using apoptosis signaling kinase related kinase (askrk)
05/19/2005CA2544764A1 Protein binding miniature proteins
05/19/2005CA2544223A1 Stabilized alpha helical peptides and uses thereof
05/19/2005CA2544214A1 Hla-dr-binding antigen peptide derived from wt1
05/19/2005CA2544145A1 Composition and method for treating macular degeneration
05/19/2005CA2543866A1 Protozoan strains of reduced virulence and use thereof
05/19/2005CA2543719A1 Methods and compositions for modulating apoptosis
05/19/2005CA2543618A1 Cytokine inhibitory drugs for treatment of macular degeneration
05/19/2005CA2543602A1 Triazole compounds and uses related thereto
05/19/2005CA2543485A1 Use of interferon-tau in medicine
05/19/2005CA2543484A1 Modulation of immune response to an immunogen with ctla-4 and tnfbp
05/19/2005CA2543481A1 G-csf therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
05/19/2005CA2543030A1 Rna interference mediated inhibition of cholesteryl ester transfer protein (cetp) gene expression using short interfering nucleic acid (sina)
05/19/2005CA2543013A1 Rna interference mediated inhibition of nogo and nogo receptor gene expression using short interfering nucleic acid (sina)
05/19/2005CA2542835A1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
05/19/2005CA2542527A1 Rna interferance mediated inhibition of cholinergic muscarinic receptor (chrm3) gene expression using short interfering nucleic acid /sina)
05/19/2005CA2537759A1 Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t cells
05/19/2005CA2534995A1 The use of plp with peg-rmetase in vivo for enhanced efficacy
05/18/2005EP1531181A2 Therapeutic oligonucleotides targeting the human mdr1 and mrp genes
05/18/2005EP1531168A1 Process for the removal of porogens from temperature sensitive macroreticular polymers using steam at reduced pressure
05/18/2005EP1531161A2 Human epidermal proteins HEPI-1 to HEPI-6
05/18/2005EP1531160A1 Recovery of a heat shock protein
05/18/2005EP1531159A1 Peptide useful for diagnosis and therapy of tumors
05/18/2005EP1530973A2 Methods for inducing T cell tolerance to a tissue or organ graft
05/18/2005EP1530967A1 Blister pack and solid dosage form comprising desmopressin
05/18/2005EP1530725A1 Materials and methods for inductions of immune tolerance
05/18/2005EP1530720A2 Breast cancer eradication program
05/18/2005EP1530643A2 Chimeric protein
05/18/2005EP1530638A2 T-cell epitopes in staphylococcal enterotoxin b
05/18/2005EP1530636A1 Treatment of melanoma by reduction in clusterin levels
05/18/2005EP1530632A2 Growth factor which acts through erb b-4 rtk
05/18/2005EP1530591A2 Nuclear hormone receptor ligand-binding domain containing protein
05/18/2005EP1530590A2 Triggering receptors expressed on myeloid cells (trem)-4 and -5 and uses thereof
05/18/2005EP1530589A2 Fragments of proinsulin c-peptide
05/18/2005EP1530588A2 Long lasting natriuretic peptide derivatives
05/18/2005EP1530584A2 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
05/18/2005EP1530582A2 Diagnosis of kidney damage and protection against same
05/18/2005EP1530494A1 A pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease
1 ... 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 ... 3163